Targeting tumor cell destruction with CD64-directed bispecific fusion proteins

Cancer Immunol Immunother. 1997 Nov-Dec;45(3-4):124-7. doi: 10.1007/s002620050413.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibodies, Bispecific / genetics
  • Antibodies, Bispecific / isolation & purification
  • Antibodies, Bispecific / metabolism*
  • Antibody-Dependent Cell Cytotoxicity
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism*
  • Epidermal Growth Factor / genetics
  • Epidermal Growth Factor / metabolism
  • ErbB Receptors / metabolism*
  • Genetic Vectors
  • Glycoproteins / genetics
  • Glycoproteins / metabolism*
  • Humans
  • Intercellular Adhesion Molecule-1 / metabolism
  • Interferon-gamma / pharmacology
  • Neuregulin-1*
  • Receptors, IgG / genetics
  • Receptors, IgG / metabolism*
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / isolation & purification
  • Recombinant Fusion Proteins / metabolism*
  • Transfection
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / metabolism

Substances

  • Antibodies, Bispecific
  • Carrier Proteins
  • Glycoproteins
  • Neuregulin-1
  • Receptors, IgG
  • Recombinant Fusion Proteins
  • Intercellular Adhesion Molecule-1
  • heregulin beta1
  • Epidermal Growth Factor
  • Interferon-gamma
  • ErbB Receptors